- Events & ActivityEvents & Activity
- CLINICAL TRIAL UPDATE - Positive VAL201 Results
- Yorkville CLN Conversion
- European Patent Granted for Lead Compound VAL201
- Convertible Loan Facility
- ValiSeek Clinical Development Update
- Quarterly Update on Clinical Developments
- Corporate Video re Clinical Status Q4, 2016
- Patent Update
- Holding(s) in Company
- Update on Recent Presentations
ValiRx PLC (VAL:LSE) closed at 3.75, 2.04% above its 52-week low of 3.68, set on Feb 23, 2017.
3.68Feb 23 201717.30May 16 2016
|Market cap||3.21m GBP|
|EPS (TTM)||-0.0664 GBP|
Data delayed at least 20 minutes, as of Feb 24 2017 16:22 GMT.